Correlation Between Senti Biosciences and Structure Therapeutics
Can any of the company-specific risk be diversified away by investing in both Senti Biosciences and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Senti Biosciences and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Senti Biosciences and Structure Therapeutics American, you can compare the effects of market volatilities on Senti Biosciences and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Senti Biosciences with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Senti Biosciences and Structure Therapeutics.
Diversification Opportunities for Senti Biosciences and Structure Therapeutics
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Senti and Structure is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Senti Biosciences and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Senti Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Senti Biosciences are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Senti Biosciences i.e., Senti Biosciences and Structure Therapeutics go up and down completely randomly.
Pair Corralation between Senti Biosciences and Structure Therapeutics
Given the investment horizon of 90 days Senti Biosciences is expected to generate 3.21 times more return on investment than Structure Therapeutics. However, Senti Biosciences is 3.21 times more volatile than Structure Therapeutics American. It trades about 0.02 of its potential returns per unit of risk. Structure Therapeutics American is currently generating about 0.04 per unit of risk. If you would invest 1,673 in Senti Biosciences on November 2, 2024 and sell it today you would lose (1,231) from holding Senti Biosciences or give up 73.58% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Senti Biosciences vs. Structure Therapeutics America
Performance |
| Timeline |
| Senti Biosciences |
| Structure Therapeutics |
Senti Biosciences and Structure Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Senti Biosciences and Structure Therapeutics
The main advantage of trading using opposite Senti Biosciences and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Senti Biosciences position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.| Senti Biosciences vs. Cadrenal Therapeutics, Common | Senti Biosciences vs. Foghorn Therapeutics | Senti Biosciences vs. Quoin Pharmaceuticals Ltd | Senti Biosciences vs. SAB Biotherapeutics |
| Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |